Giuseppe Argenziano
Distinguished in Frostbite

Giuseppe Argenziano

Naples, IT 
Distinguished in Frostbite
Naples, IT 
OverviewLocationsClinical Research

Overview

Giuseppe Argenziano practices in Naples, Italy. Mr. Argenziano is rated as a Distinguished expert by MediFind in the treatment of Frostbite. His top areas of expertise are Melanoma, Basal Cell Skin Cancer, Seborrheic Keratosis, Pigmented Purpuric Dermatosis, and Lymphadenectomy.

His clinical research consists of co-authoring 798 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Frostbite.

Gender
Male

Locations

Naples, Italy
Other Locations
Caserta, Italy
Italy
Dr. Sperduti Is With The Biostatistical Unit, Regina Elena, Italy
Reggio Nell'emilia, Italy
Santa Maria Nuova, Italy
Benevento, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Randomised Double-blind Parallel-group Study to Evaluate the Long-term Effects of Eryfotona AK-NMSC® Cream in the Treatment of Cancerization Field in Patients With Actinic Keratosis.
A Randomised Double-blind Parallel-group Study to Evaluate the Long-term Effects of Eryfotona AK-NMSC® Cream in the Treatment of Cancerization Field in Patients With Actinic Keratosis.
Enrollment Status: Unknown
Publish Date: October 11, 2013
Intervention Type: Other, Device
Study Phase: Phase 4
View 1 Less Clinical Trial

797 Total Publications

Successful treatment of a recalcitrant digital wart with topical methotrexate: a rationale for antiviral action.
Successful treatment of a recalcitrant digital wart with topical methotrexate: a rationale for antiviral action.
Journal: Italian journal of dermatology and venereology
Published: October 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Argenziano's expertise for a condition
ConditionClose
View All 23 Distinguished Conditions
View All 43 Advanced Conditions
View All 89 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile